​

Funding Round

Series E - Ginkgo Bioworks

Series E - Ginkgo Bioworks

Investment Firm

Overview

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Announced Date

Sep 19, 2019

Closed on Date

Sep 19, 2019

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorViking Global Investors
Participant InvestorT. Rowe Price
Participant InvestorGeneral Atlantic
Participant InvestorCascade Investment

Round Details and Background

Ginkgo Bioworks raised $290000000 on 2019-09-19 in Series E

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Company Funding History

18

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 10, 2024
Grant - Ginkgo Bioworks
1-undefined
Jun 08, 2016
Series C - Ginkgo Bioworks
6-100.0M
Jul 23, 2015
Series B - Ginkgo Bioworks
11-53.3M
Jul 16, 2014
Seed Round - Ginkgo Bioworks
14-1.0M

Recent Activity

There is no recent news or activity for this profile.